Executive Medical Director, Early Clinical Development Oncology in Newtown

We are seeking a high performing Executive Director to join our Early Oncology Clinical Leadership team, working directly with Discovery areas, and managing a team of 6-10 physicians. This is an opportunity for a well-trained clinician with strong leadership skills who is driven by science and the desire to develop innovative therapies for cancer patients. The successful candidate will have a mastery of the drug development process, notably in early phase clinical trials, protocol writing, study conduct, data review and reconciliation, the principles of translational medicine, and what it takes to lead teams successfully. This role allows for growth and development while working in a collaborative, vibrant environment.

Responsibilities

• Leading a team of Clinical Development professionals, you will work directly with a sub-set of "Discovery" areas which may include areas like Immuno‑Oncology, Cell Therapy, Anti‑body Drug Conjugate, Tumour Driver, DNA Damage Response and Epigenetics Drug Development projects.
• Planning, implementing, and managing the daily operation of assigned drug development projects.
• Participating in Discovery extended leadership teams and late‑stage steering councils.
• Collaborating effectively with key internal and external stakeholders.
• Contributing to and supporting Department/Clinical initiatives to improve the quality and content of all clinical programs as well as the cross‑functional/organization processes designed to effectively deliver our R&D portfolio.

Typical Duties

• Direct/Oversee the design and implementation of early-stage clinical projects, as a member of our Product Development Team (PDT) and leader of the Clinical Sub‑Team (CST). Ensure that the overall scientific and medical content of all clinical programs is scientifically and clinically rigorous.
• Prepare clinical development plans that integrate pre‑clinical and early clinical findings while working to ensure cross‑functional alignment on an ongoing basis throughout the early phases of clinical development.
• Design scientifically rigorous and maximally cost‑effective clinical protocols that are aligned with the clinical development plan.
• Present and defend protocols and clinical development plans at internal governance forums.
• Serve as Medical Monitor, responsible for the safety monitoring of clinical trials, and as medical expert for Phase I/II studies, managing the process from protocol development through individual study report and integrated regulatory documentation.
• Provide oversight and guidance to clinical team activities at the Product Development Team, Clinical Study Team, Clinical Trial Team, and Translational Science Sub‑Team.
• Monitor study progress, ensure proper study conduct and adherence to the protocol, lead data review, evaluation, and analyses with support from Data Management and Stats & Programming team.
• Present study updates, interim results, and final headline data to senior management as required.
• Prepare various official and regulatory documents for Regulatory and other agencies, such as Dossiers, BLAs, INDs, Safety and Annual reports, handling responses to regulatory agencies regarding questions about complex clinical development issues (e.g., safety or efficacy).
• Ensure that Serious Adverse Events are properly reported on a global basis.
• Lead cross‑functional teams comprised of multidisciplinary professionals and clinical scientists. Direct responsibility for leading a team of Clinical Development professionals and ensure delivery of their portfolio of assets.
• Implement clinical R&D policies, SOPs and related directives.
• Review potential in‑licensing candidates and present recommendations to Senior Management groups.
• Support any needed due diligence and prepare/present medically sound strategy and plans associated with advanced opportunities.
• Contribute and support Department/Clinical initiatives to improve the quality and content of all clinical programs as well as the cross‑functional/organization processes designed to effectively deliver our R&D portfolio.

Qualifications

• MD or international equivalent is required, Medical Oncology specialty and sub‑specialty training is required, Board Certification is preferred.
• Clinical or research experience (in an academic or pharmaceutical environment) related to the design and/or conduct of clinical studies in oncology is required.
• Significant experience (7+ years) in clinical research and/or Oncology drug development in pharmaceutical environment.

Desired Qualifications

• MD/PhD or equivalent
• Credible with key external oncology stakeholders, payers, and oncology scientific communities.

Company Overview

We are a science‑based, leading, and decisive Oncology enterprise united in our vision to eliminate cancer as a cause of death. The pioneers, we make bold moves that transform the way cancer is treated and truly improve patient outcomes. With one of the broadest and deepest Oncology pipelines in the industry, there are many opportunities to work with new and novel drugs and help discover what’s next. Supportive team players, we draw on diverse knowledge from across the business and external partners to come to bear on the toughest medical challenges. Empowered by the business and each other, we embody courage and curiosity - taking smart risks, challenging the norm, and learning from failures. Be at the forefront of applying science to studies and using innovative approaches to create new possibilities. We take an inter‑disciplinary approach including novel biomarkers, AI, novel endpoints, and cutting‑edge trial designs to shape the future of our business and Oncology.